Maninder Hora

Dr. Maninder Hora currently serves as the Chief Technical Operations Officer of Amunix. Dr. Hora has served the biopharmaceutical industry for more than 30 years with demonstrated leadership in process, analytical and pharmaceutical sciences, manufacturing and quality functions. He has been part of teams that have successfully filed 50+ INDs and registered 11 biopharmaceutical products worldwide. Prior to joining Amunix, he served as the Chief Technical Operations Officer of Nektar Therapeutics, where he spearheaded strategic direction and execution of all process and product development as well as manufacturing activities. Prior to Nektar, he served as Vice President of Product Operations & Quality at Facet Biotech/ PDL BioPharma (now a part of Abbvie) and Vice President of Process and Product Development at Chiron Corporation (now Novartis). Prior to that, he held positions of increasing responsibilities at Chiron, Pfizer and GSK.

Dr. Hora received his Ph.D. from the Indian Institute of Technology in Bioengineering (Materials) in 1980 and held a Fulbright fellowship at the University of Washington, Seattle. He holds 23 US Patents and has authored scores of publications and delivered numerous presentations in international forums. He serves on the Scientific Advisory Board for Cristal Therapeutics, an emerging nanotechnology-based biopharmaceutical company.